Is a complete FRA/MDG1 research report available?

No complete published report is available for fra/MDG1 (FRA/MDG1) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/MDG1 (FRA/MDG1)

Frankfurt Stock Exchange: FRA/MDG1 · EUR

€0.02

+0.00 (+3.6%)· Recorded snapshot

Market cap	256.1K
Revenue (ttm)	7.4M
Net income (ttm)	-15.9M
EPS (ttm)	-€1.26
Shares out	14.9M
Beta	1.45

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.4M
Net income (ttm): -15.9M
EPS (ttm): -€1.26
Market cap: 256.1K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-06 02:00 UTC

All FRA/MDG1 indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

EUR

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	87
Employees Change	0%
Employees Change Percent	0
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	DE000A40ESG2
Last refreshed	2026-09-06
Market cap	EUR 256,067
Price	EUR 0.02
Price currency	EUR
Rev Per Employee	85,586.21x
Sector	Healthcare
Sector PE	37.99
Sector PE Fwd	14.33
Sic	2836
Symbol	fra/MDG1
Website	https://www.medigene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6,222.2%
FCF yield	-5,777.39%
P/B ratio	0.01x
P/S ratio	0.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-207.04%
EBITDA Margin	-198.51%
Gross margin	79.94%
Gross Profit	EUR 6M
Gross Profit Growth	-14.2%
Gross Profit Growth Q	1.63%
Gross Profit Growth3 Y	-3.85%
Gross Profit Growth5 Y	11.13%
Net Income	EUR -15.9M
Pretax Margin	-209.76%
Profit Margin	-213.98%
Profit Per Employee	EUR -183,138
ROA	-27.15
Roa5y	-9.61
ROCE	-69.2
ROE	-63.93
Roe5y	-32.16
ROIC	-198.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-48.35%
Cagr15y	-35.39%
Cagr1y	-85.19%
Cagr20y	-32.73%
Cagr3y	-83.15%
Cagr5y	-70.34%
Revenue Growth	-17.51x
Revenue Growth Q	-6x
Revenue Growth Qo Q	-34.9x
Revenue Growth3 Y	-4.76x
Revenue Growth5 Y	-3.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.21
Assets	EUR 28.8M
Cash	EUR 14M
Current Assets	EUR 15.6M
Current Liabilities	EUR 6.5M
Debt	EUR 2.5M
Debt Equity	EUR 0.13
Debt FCF	EUR -0.17
Equity	EUR 19.7M
Interest Coverage	-28.34
Liabilities	EUR 9.2M
Long Term Assets	EUR 13.2M
Long Term Liabilities	EUR 2.6M
Net Cash	EUR 11.5M
Net Cash By Market Cap	EUR 4,483
Net Cash Growth	-45.51%
Net Debt Equity	EUR -0.58
Tangible Book Value	EUR 9.8M
Tangible Book Value Per Share	EUR 0.67
WACC	16.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.39
Net Working Capital	EUR -4M
Quick ratio	2.22
Working Capital	EUR 9.1M
Working Capital Turnover	EUR 0.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.86%
1Y total return	-85.17%
200-day SMA	0.04
3Y total return	-99.52%
50-day SMA	0.02
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.77%
All Time High	1,004
All Time High Change	-100%
All Time High Date	2000-10-02
All Time Low	0.01
All Time Low Change	36.51%
All Time Low Date	2026-04-16
ATR	0
Beta	1.45
Beta1y	2.91
Beta2y	1.5
Ch YTD	-15.69
High	0.02
High52	0.15
High52 Date	2025-07-07
High52ch	-88.3%
Low	0.02
Low52	0.01
Low52 Date	2026-04-16
Low52ch	36.51%
Ma50ch	-29.8%
Price vs 200-day SMA	-54.62%
RSI	42.2
RSI Monthly	28.59
RSI Weekly	34.41
Sharpe ratio	0.45x
Sharpe Ratio3y	-0.05x
Sharpe Ratio5y	-0.09x
Sortino ratio	0.97
Sortino Ratio3y	-0.05
Sortino Ratio5y	-0.12
Total Return	-2.65%
Tr YTD	-15.69
Tr15y	-99.86%
Tr1m	-36.3%
Tr1w	-29.51%
Tr3m	-41.89%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-1,783,000
Shares Out	14,887,594
Shares Qo Q	5.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -15.1M
Adjusted OCF	-14,447,000
Average Volume	5,555.1x
Bv Per Share	1.33
CAPEX	EUR -621,000
Ch10y	-99.87
Ch15y	-99.87
Ch1m	-36.3
Ch1w	-29.51
Ch1y	-85.17
Ch20y	-99.97
Ch3m	-41.89
Ch3y	-99.55
Ch5y	-99.78
Ch6m	-28.93
Change	3.61%
Change From Open	0
Close	0.02
Days Gap	3.61
Depreciation Amortization	635,000
EBIT	EUR -15.4M
EBITDA	EUR -14.8M
EPS	EUR -1.26
F Score	3
FCF	EUR -14.8M
FCF Per Share	EUR -0.99
Financing CF	4,112,000
Fiscal Year End	December
Founded	1,994
Income Tax	EUR 314,000
Investing CF	7,527,000
Is Primary Listing	1
Last Earnings Date	2025-08-15
Last Report Date	2024-06-30
Last Split Date	2024-08-29
Last Split Type	Reverse
Ma150	0.03
Ma150ch	-45.4%
Ma20	0.02
Ma20ch	-14.43%
Net CF	-2,526,000
Open	0.02
Ppne	3,057,000
Price Date	2026-06-30
Ptbv Ratio	0.03
Relative Volume	0.07x
Revenue	7,446,000x
SBC By Revenue	3.68x
Share Based Comp	274,000
Tax By Revenue	4.22x
Tr20y	-99.96%
Tr6m	-28.93%
Z Score	-22.41

FRA/MDG1 (FRA/MDG1)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/MDG1

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/MDG1 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on FRA/MDG1

Frequently asked questions